标题
Recent advances in the treatment of life-threatening, invasive fungal infections
作者
关键词
-
出版物
EXPERT OPINION ON PHARMACOTHERAPY
Volume 14, Issue 17, Pages 2361-2374
出版商
Informa Healthcare
发表日期
2013-09-19
DOI
10.1517/14656566.2013.838217
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Voriconazole therapeutic drug monitoring: retrospective cohort study of the relationship to clinical outcomes and adverse events
- (2013) Helen Y Chu et al. BMC INFECTIOUS DISEASES
- Immunotherapy for Invasive Mold Disease in Severely Immunosuppressed Patients
- (2013) A. Safdar CLINICAL INFECTIOUS DISEASES
- Finding the “Missing 50%” of Invasive Candidiasis: How Nonculture Diagnostics Will Improve Understanding of Disease Spectrum and Transform Patient Care
- (2013) Cornelius J. Clancy et al. CLINICAL INFECTIOUS DISEASES
- Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations
- (2013) Barbara D. Alexander et al. CLINICAL INFECTIOUS DISEASES
- Advances in Identification of Clinical Yeast Isolates by Use of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry
- (2013) B. W. Buchan et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Combination Antifungal Therapy for Cryptococcal Meningitis
- (2013) Jeremy N. Day et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multiplex PCR System for Rapid Detection of Pathogens in Patients with Presumed Sepsis – A Systemic Review and Meta-Analysis
- (2013) Shy-Shin Chang et al. PLoS One
- T2 Magnetic Resonance Enables Nanoparticle-Mediated Rapid Detection of Candidemia in Whole Blood
- (2013) L. A. Neely et al. Science Translational Medicine
- Adjunctive interferon-γ immunotherapy for the treatment of HIV-associated cryptococcal meningitis
- (2012) Joseph N. Jarvis et al. AIDS
- Echinocandin Resistance in Candida Species: Mechanisms of Reduced Susceptibility and Therapeutic Approaches
- (2012) Nicholas D Beyda et al. ANNALS OF PHARMACOTHERAPY
- T-2307 Causes Collapse of Mitochondrial Membrane Potential in Yeast
- (2012) Tatsuya Shibata et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of a New Oral Glucan Synthase Inhibitor (MK-3118) Tested against Aspergillus spp. by CLSI and EUCAST Broth Microdilution Methods
- (2012) M. A. Pfaller et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Prospective, Observational Study of Voriconazole Therapeutic Drug Monitoring among Lung Transplant Recipients Receiving Prophylaxis: Factors Impacting Levels of and Associations between Serum Troughs, Efficacy, and Toxicity
- (2012) Dimitra Mitsani et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Posaconazole Exposure-Response Relationship: Evaluating the Utility of Therapeutic Drug Monitoring
- (2012) Michael J. Dolton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Synthesis and biological evaluation of antifungal derivatives of enfumafungin as orally bioavailable inhibitors of β-1,3-glucan synthase
- (2012) Brian H. Heasley et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Septic Shock Attributed to Candida Infection: Importance of Empiric Therapy and Source Control
- (2012) M. Kollef et al. CLINICAL INFECTIOUS DISEASES
- Combination Therapy for Mucormycosis: Why, What, and How?
- (2012) Brad Spellberg et al. CLINICAL INFECTIOUS DISEASES
- (1,3)- -D-Glucan as a Prognostic Marker of Treatment Response in Invasive Candidiasis
- (2012) S. Jaijakul et al. CLINICAL INFECTIOUS DISEASES
- Polymerase Chain Reaction-Based Assays for the Diagnosis of Invasive Fungal Infections
- (2012) T. K. Kourkoumpetis et al. CLINICAL INFECTIOUS DISEASES
- Post-diagnostic kinetics of the (1 → 3)-β-d-glucan assay in invasive aspergillosis, invasive candidiasis and Pneumocystis jirovecii pneumonia
- (2012) S. Koo et al. CLINICAL MICROBIOLOGY AND INFECTION
- The PATH (Prospective Antifungal Therapy) Alliance® registry and invasive fungal infections: update 2012
- (2012) Nkechi Azie et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- A new solid oral tablet formulation of posaconazole: a randomized clinical trial to investigate rising single- and multiple-dose pharmacokinetics and safety in healthy volunteers
- (2012) G. Krishna et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of MK-3118, a new oral glucan synthase inhibitor, tested against Candida spp. by two international methods (CLSI and EUCAST)
- (2012) M. A. Pfaller et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Correlation of Clinical Outcomes with β-Glucan Levels in Patients with Invasive Candidiasis
- (2012) Charles R. Sims et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Evaluation of the Yeast Traffic Light PNA FISH Probes for Identification of Candida Species from Positive Blood Cultures
- (2012) L. Hall et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Early Serum Galactomannan Trend as a Predictor of Outcome of Invasive Aspergillosis
- (2012) L. Y. A. Chai et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Cost of Invasive Fungal Infections in the Era of New Diagnostics and Expanded Treatment Options
- (2012) Elizabeth Dodds Ashley et al. PHARMACOTHERAPY
- Aspergillus Infection and Extracorporeal Membrane Oxygenation Support
- (2012) Xiomara Garcia et al. JOURNAL OF INTENSIVE CARE MEDICINE
- Invasive Mycoses: Diagnostic Challenges
- (2011) Luis Ostrosky-Zeichner AMERICAN JOURNAL OF MEDICINE
- Caspofungin Dose Escalation for Invasive Candidiasis Due to Resistant Candida albicans
- (2011) Nathan P. Wiederhold et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Disseminated Candidiasis Caused by Candida albicans with Amino Acid Substitutions in Fks1 at Position Ser645 Cannot Be Successfully Treated with Micafungin
- (2011) J. L. Slater et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Phase II Dose Escalation Study of Caspofungin for Invasive Aspergillosis
- (2011) O. A. Cornely et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy of Oral E1210, a New Broad-Spectrum Antifungal with a Novel Mechanism of Action, in Murine Models of Candidiasis, Aspergillosis, and Fusariosis
- (2011) Katsura Hata et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivity of E1210, a Novel Antifungal, against Clinically Important Yeasts and Molds
- (2011) Mamiko Miyazaki et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Earlier Response Assessment in Invasive Aspergillosis Based on the Kinetics of Serum Aspergillus Galactomannan: Proposal for a New Definition
- (2011) S. A. Nouer et al. CLINICAL INFECTIOUS DISEASES
- -D-Glucan Assay for the Diagnosis of Invasive Fungal Infections: A Meta-analysis
- (2011) D. E. Karageorgopoulos et al. CLINICAL INFECTIOUS DISEASES
- Diagnosing invasive fungal disease in critically ill patients
- (2011) Joe L. Hsu et al. CRITICAL REVIEWS IN MICROBIOLOGY
- The case for antifungal stewardship
- (2011) Michelle R. Ananda-Rajah et al. CURRENT OPINION IN INFECTIOUS DISEASES
- The Deferasirox–AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial
- (2011) Brad Spellberg et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Performance and Cost Analysis of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Routine Identification of Yeast
- (2011) N. Dhiman et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Direct MALDI-TOF Mass Spectrometry Assay of Blood Culture Broths for Rapid Identification of Candida Species Causing Bloodstream Infections: an Observational Study in Two Large Microbiology Laboratories
- (2011) Teresa Spanu et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Prospective Evaluation of Clinical and Biological Markers To Predict the Outcome of Invasive Pulmonary Aspergillosis in Hematological Patients
- (2011) A. Bergeron et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Current Concepts in Antifungal Pharmacology
- (2011) Russell E. Lewis MAYO CLINIC PROCEEDINGS
- The economic costs to United States hospitals of invasive fungal infections in transplant patients
- (2010) Joseph Menzin et al. AMERICAN JOURNAL OF INFECTION CONTROL
- Recent Exposure to Caspofungin or Fluconazole Influences the Epidemiology of Candidemia: a Prospective Multicenter Study Involving 2,441 Patients
- (2010) Olivier Lortholary et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- T-2307 Shows Efficacy in a Murine Model of Candida glabrata Infection despite In Vitro Trailing Growth Phenomena
- (2010) E. Yamada et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Continuous Infusion of Amphotericin B Deoxycholate in the Treatment of Cryptococcal Meningoencephalitis: Analysis of Safety and Fungicidal Activity
- (2010) Diego Rodrigues Falci et al. CLINICAL INFECTIOUS DISEASES
- Invasive Fungal Infections among Organ Transplant Recipients: Results of the Transplant‐Associated Infection Surveillance Network (TRANSNET)
- (2010) Peter G. Pappas et al. CLINICAL INFECTIOUS DISEASES
- Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
- (2010) John R. Perfect et al. CLINICAL INFECTIOUS DISEASES
- Overall survival and fungal infection-related mortality in patients with invasive fungal infection and neutropenia after myelosuppressive chemotherapy in a tertiary care centre from 1995 to 2006
- (2010) C. Hahn-Ast et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- PCR Diagnosis of Invasive Candidiasis: Systematic Review and Meta-Analysis
- (2010) T. Avni et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Efungumab: A Novel Agent in the Treatment of Invasive Candidiasis
- (2009) Rakhi Karwa et al. ANNALS OF PHARMACOTHERAPY
- Safety and Outcomes of Open-Label Deferasirox Iron Chelation Therapy for Mucormycosis
- (2009) B. Spellberg et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effect of Mild and Moderate Liver Disease on the Pharmacokinetics of Isavuconazole after Intravenous and Oral Administration of a Single Dose of the Prodrug BAL8557
- (2009) A. Schmitt-Hoffmann et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics and Pharmacodynamics of a Novel Triazole, Isavuconazole: Mathematical Modeling, Importance of Tissue Concentrations, and Impact of Immune Status on Antifungal Effect
- (2009) P. A. Warn et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America
- (2009) Peter G. Pappas et al. CLINICAL INFECTIOUS DISEASES
- Infections after the use of alemtuzumab in solid organ transplant recipients: a comparative study
- (2009) Nasia Safdar et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- An update on the molecular diagnosis of invasive fungal disease
- (2009) P. Lewis White et al. FEMS MICROBIOLOGY LETTERS
- The iron chelator deferasirox enhances liposomal amphotericin B efficacy in treating murine invasive pulmonary aspergillosis
- (2009) A. S. Ibrahim et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A safety and feasibility study comparing an intermittent high dose with a daily standard dose of liposomal amphotericin B for persistent neutropenic fever
- (2009) M. Ellis et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis
- (2009) Carlo Mengoli et al. LANCET INFECTIOUS DISEASES
- Continuous infusion of amphotericin B deoxycholate: an innovative, low-cost strategy in antifungal treatment
- (2009) Diego R. Falci et al. MYCOSES
- MALDI-TOF MS-based drug susceptibility testing of pathogens: The example ofCandida albicansand fluconazole
- (2009) Carine Marinach et al. PROTEOMICS
- Measurement of (1-3)-β-D-Glucan Derived from Different Gauze Types
- (2009) Hajime Kanamori et al. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
- In Vitro Activity of the New Azole Isavuconazole (BAL4815) Compared with Six Other Antifungal Agents against 162 Cryptococcus neoformans Isolates from Cuba
- (2008) M.-T. Illnait-Zaragozi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro and In Vivo Antifungal Activities of T-2307, a Novel Arylamidine
- (2008) J. Mitsuyama et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Antifungal Activities of Isavuconazole (BAL4815), Voriconazole, and Fluconazole against 1,007 Isolates of Zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium Species
- (2008) J. Guinea et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antifungal Therapeutic Drug Monitoring: Established and Emerging Indications
- (2008) D. Andes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- -D-Glucan Detection Test: A Step Toward Preemptive Therapy for Fungal Infections in Leukemic Patients?
- (2008) R. Herbrecht et al. CLINICAL INFECTIOUS DISEASES
- 1,3- -D-Glucan Antigenemia for Early Diagnosis of Invasive Fungal Infections in Neutropenic Patients with Acute Leukemia
- (2008) L. Senn et al. CLINICAL INFECTIOUS DISEASES
- Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
- (2008) Thomas J. Walsh et al. CLINICAL INFECTIOUS DISEASES
- Factors Associated with Candidemia Caused by Non‐albicans CandidaSpecies VersusCandida albicansin the Intensive Care Unit
- (2008) Jennifer K. Chow et al. CLINICAL INFECTIOUS DISEASES
- Delaying Amphotericin B–Based Frontline Therapy Significantly Increases Mortality among Patients with Hematologic Malignancy Who Have Zygomycosis
- (2008) Georgios Chamilos et al. CLINICAL INFECTIOUS DISEASES
- Reappraisal of the Serum (1→3)‐β‐D‐Glucan Assay for the Diagnosis of Invasive Fungal Infections—A Study Based on Autopsy Cases from 6 Years
- (2008) Taminori Obayashi et al. CLINICAL INFECTIOUS DISEASES
- Combination antifungal therapy: a critical review of the evidence
- (2008) L. Ostrosky-Zeichner CLINICAL MICROBIOLOGY AND INFECTION
- Contribution of new diagnostic approaches to antifungal treatment plans in high-risk haematology patients
- (2008) H. Einsele et al. CLINICAL MICROBIOLOGY AND INFECTION
- Efungumab and caspofungin: pre-clinical data supporting synergy
- (2008) S. Hodgetts et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Evaluation of aminocandin and caspofungin against Candida glabrata including isolates with reduced caspofungin susceptibility
- (2008) G. E. Brzankalski et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes
- (2007) A. Pascual et al. CLINICAL INFECTIOUS DISEASES
- False-positive Aspergillus antigen testing due to application of piperacillin/tazobactam—is it still an issue?
- (2007) Olaf Penack et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now